Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isovue-370 vs Visipaque 320 in Pulmonary MDCTA
NCT00351754Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iopamidol in pulmonary embolism (PE), sponsored by Bracco Diagnostics Inc. Primary endpoint: Hounsfield Units. Started Jul 2006; status: completed.
02
Drugs
iopamidol
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00351754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351754.